Opendata, web and dolomites

KWatch Glucose

K'Watch Glucose: A ground-breaking biometric wearable for painless, minimally invasive and blood-free glucose monitoring.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 KWatch Glucose project word cloud

Explore the words cloud of the KWatch Glucose project. It provides you a very rough idea of what is the project "KWatch Glucose" about.

million    device    standpoints    relies    skin    times    foreseen    life    regimen    self    shape    wearable    worldwide    giving    impacts    anywhere    commercial    monitor    preparation    71    performance    persistent    time    imbalance    adherence    monitoring    launch    threatening    run    invasive    blood    profits    events    maturity    patented    independently    lives    financial    roi    smart    levels    day    pkparis    poor    routines    replacements    642    expecting    evident    healthcare    incompatible    feasibility    consuming    glucose    fail    anytime    frequent    biometric    prevent    form    noticing    watch    accurate    business    constraint    rear    people    costly    daily    77    diabetes    social    88    hidden    bulky    insulin    invested    ing    reaching    global    stick    minimally    boost    finalise    validated    solution    depends    2040    burden    manner    helps    market    disease    stigma    biosensor    thorough    painful    billion    80    warrant   

Project "KWatch Glucose" data sheet

The following table provides information about the project.

Coordinator
PKVITALITY 

Organization address
address: 14 AVENUE DE L'OPERA
city: PARIS
postcode: 75001
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.pkvitality.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PKVITALITY FR (PARIS) coordinator 50˙000.00

Map

 Project objective

Diabetes is a global burden expected to affect 642 million people by 2040. In Europe, this disease affects 60 million people and costs over €90 billion to our constraint healthcare system. Today a major part of diabetes management relies on the monitoring of blood glucose levels several times a day. Monitoring needs to be thorough, frequent and accurate, to prevent a persistent imbalance in glucose-insulin levels and the resulting life-threatening events. Although the lives of 70 million diabetes cases worldwide depends on glucose monitoring several times per day, 80% of them fail to stick to this crucial regimen. One main reason is the poor performance of self-monitoring devices. Most of the monitoring systems available today measure blood glucose, becoming painful and time-consuming, often incompatible with daily routines. Some of them adopt the form of a wearable, but devices and replacements are costly, bulky and very evident, giving raise to social stigma. It is evident that new monitoring systems are needed to enhance adherence to the necessary management procedures. In response, we at PKparis have developed, patented and validated K'Watch Glucose, a unique biometric wearable device in the shape of a smart watch that includes glucose monitoring among its many features. Hidden in the rear side of the watch, our biosensor measures glucose levels in the skin, in a minimally invasive manner and independently from blood. Our easy-to-use solution enables users to monitor glucose rapidly, anywhere, anytime and with no one noticing. Before reaching market maturity we need to finalise its development and business preparation. Thus, in Phase 1 we aim to run a Feasibility Study that helps us warrant all technical, commercial and financial standpoints of the project. Along the social and market impacts foreseen for K'Watch Glucose 5 years from launch, it will also boost our growth, expecting €71.77 million in profits, 100 new people and a ROI of 30.88 per euro invested.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "KWATCH GLUCOSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "KWATCH GLUCOSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More